Liver Cancer Risk Persists After DAA Treatment for HCV

Patients with cirrhosis and those with high fibrosis-4 scores face the highest risks and should continue to be screened.
Medscape Medical News

source https://www.medscape.com/viewarticle/977173?src=rss